SAN DIEGO, Aug. 31, 2015 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., is collaborating with Davita Healthcare Partners and P2Link to develop chronic care management solutions powered by Qualcomm Life's 2net™ Device Connectivity Platform and HealthyCircles™ Care Coordination Platform to enable continuous care, informed interventions and better management of at-risk populations. The collaborations were announced at Qualcomm Life's annual Connect 2015 ecosystem conference taking place on August 31 and September 1, 2015 in San Diego, California.
Davita HealthCare Partners, one of the largest medical groups and physician network operators, provides integrated care management for approximately 830,000 patients, more than 600,000 of which live in California and represent diverse cultures, socioeconomic groups, ages, and health statuses. The company will integrate Qualcomm Life's 2net Mobile and HealthyCircles technologies into a coordinated care program for patients with heart failure (HF). Patients will be equipped with a home blood pressure monitor, a weight scale and a tablet powered by 2net Mobile to seamlessly collect and transmit the biometric data to the cloud. Patients will also leverage the HealthyCircles Platform to monitor the patient's health status at home, receive relevant educational content and targeted, proactive care management interventions. The initial program will roll out in Q4 2015.
"We are excited to be working with Qualcomm Life on our chronic care management programs," said Doug Allen, MD, MMM, senior vice president, Clinical Informatics, DaVita HealthCare Partners. "Their expertise in wireless, open ecosystem approach and robust care coordination capabilities make them an ideal partner as we seek to expand our capabilities in the delivery of optimal care to patients with chronic disease, in the comfort of their own homes."
P2Link, a provider of innovative health monitoring solutions, enables payors and providers to reduce costs while improving quality of care for patients with heart failure and chronic obstructive pulmonary disease (COPD). The company is collaborating with Qualcomm Life in the United States and Europe to deploy remote monitoring medical device kits powered by the 2net Hub and Platform for patients suffering from HF and COPD, with the first patient enrollment expected to begin in the United States in Q4 2015. Through their pay-for-performance services that leverage proprietary predictive models and an in-house clinical call center, P2Link targets to reduce the cost of care for HF and COPD patients by 10 to 15 percent, helping payors and providers as they transition to a value-based reimbursement system.
"Qualcomm Life's 2net technology enables seamless capture of medical device data from the patient's home, ultimately allowing our team to better manage at-risk patient populations while generating the savings expected by the payors and care providers we serve," said Nabil Mouline, chief operating officer, P2Link.
P2Link's first implementation of 2net will be with Emerson Hospital in Concord, Massachusetts.
"P2Link's services powered by Qualcomm Life's 2net technology will help institutions like ours capture the promise of the 'triple aim': a better care experience, improved health outcomes and lowered costs for the 300,000 individuals to whom we provide Premium Care with a Personal Touch," said Jack Wilhelm, senior vice president, Administration of Emerson Hospital.
"With our growing ecosystem of more than 500 companies, we are collaborating to develop new care models that deliver near real-time informed care that's both adaptive and patient-centered," said Rick Valencia, senior vice president and general manager, Qualcomm Life. "We are thrilled to be working with HealthCare Partners and P2Link to deliver the right care, at the right time, in the right location to the patients who need it the most."
Sponsored by GlobalLogic, LenovoHealth, Triventis Health, Striiv, vitaphone e-health solutions, DLA Piper, Orion Health and Accenture Intelligent Patient Solutions, the fourth annual Connect 2015 welcomes leaders from across the connected health industry to discuss scalable patient centered care and cost-effective management of at-risk patient populations. Speakers include Dr. Eric Topol, director of the Scripps Translational Science Institute, Mick Farrell, chief executive officer, ResMed, Adam Pellegrini, vice president of eHealth, Walgreens, Sandra Elliott, vice president of Consumer Technology and Service Development, Meridian Health and many more. The full conference agenda can be found here. For updates and to join real-time conversations from Connect 2015, follow @QualcommLife and #QualcommConnect on Twitter and visit the new Qualcomm Life Storify page.
About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm's website, OnQ blog, Twitter and Facebook pages.
Qualcomm and 2net are trademarks of QUALCOMM Incorporated, registered in the United States and other countries. HealthyCircles is a trademark of MyTeleHealth Solutions, LLC, a wholly owned subsidiary of Qualcomm Life, Inc. Other product and brand names may be trademarks or registered trademarks of their respective owners.
The 2net services are offered through Qualcomm Life, Inc. Available in the United States, Canada and the European Union. Wireless network coverage may vary. Medical device depicted may not be available at the time of this publication. Nothing in these materials is an offer to sell any of the components or devices referenced herein.
Emily Kilpatrick, Corporate Communications
Email: [email protected]
Jamie Eisinger, Qualcomm Life, Inc.
Email: [email protected]
Warren Kneeshaw, Investor Relations
Email: [email protected]
SOURCE Qualcomm Incorporated